AEMD Webcast Alert

Aethlon Medical, Inc. Presentation at Informed Investors Biotechnology/Healthcare Virtual Stocks Forum to be Webcast on Tuesday, July 27, 2004, 10:00 am ET

LA JOLLA, Ca (PRWEB) July 26, 2004 -- Aethlon Medical, Inc. (OTCBB: AEMD) will present at the following forum:

What: Aethlon Medical, Inc. (OTCBB: AEMD) will give a presentation at Informed Investors Biotechnology /Healthcare Virtual Stocks Forum

When: July 27, 2004 @ 10:00 AM Eastern Time

Where: http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85119

How:    Live over the Internet - Simply log on to the web at the address above.

Contact: James Joyce, Chief Executive Officer,
             jimjoyce@aethlonmedical.com

If you are unable to attend the live event, the forum will be available via webcast at http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85119.

Aethlon Medical is pioneering the development of viral filtration devices that rapidly reduce the presence of infectious disease and toxins in the body. Aethlon has published compelling human blood studies of the Hemopurifier(TM) to treat HIV/AIDS and Hepatitis-C (HCV), and most recently, has announced that it is developing pathogen filtration devices to treat infectious agents used in biological warfare and terrorism. The Hemopurifier is a proprietary platform technology that converges the established scientific principles of affinity chromatography and hemodialysis as a means to augment the immune response of clearing viruses and toxins from the blood before cell and organ infection can occur. On March 4, 2004, Aethlon announced a cooperative agreement with the National Center for Biodefense (NCBD) at George Mason University.

Under the agreement, Aethlon and the NCBD will collaborate to develop pathogen and toxin filtration devices designed to protect the lives of U.S. Military personnel exposed to infectious agents as a result of biological warfare.

For additional information, visit the company's Web site at http://www.AethlonMedical.com.

FORUM CONTACT: Cary Loeser, Informed Investors, 804-327-3407, cloeser@wilink.com

Web site: http://www.informedinvestors.com

SOURCE Aethlon Medical, Inc.

James Joyce, Chief Executive Officer of Aethlon Medical, Inc.,
jimjoyce@aethlonmedical.com; or Cary Loeser, Informed Investors,
+1-804-327-3407, cloeser@wilink.com

Aethlon Medical, Inc. is a featured Company on www.HomelandDefenseStocks.com and www.investorideas.com/Research/Industries/Biotech.asp

###